Nakatoh Shinichi
Department of Orthopaedic Surgery, Asahi General Hospital, Japan.
Clin Calcium. 2014 May;24(5):719-26.
The current low osteoporosis treatment rate (20%) in Japan is problematic. Osteoporosis screening is needed to ensure that asymptomatic osteoporosis patients are identified and treated. However, five problems are associated with osteoporosis screening in Japan. First, among 1,783 district municipalities, osteoporosis screening was performed in only 1,062 municipalities in 2011. The performance rate is approximately 60% every year. Often, screening was not performed because of financial reasons. Second, the screening participation rates are low and vary among districts (0 - 15%). Third, the bone mineral density measuring apparatus is not sufficiently and widely available for osteoporosis screening. Fourth, the screening results are mainly determined from bone mineral densities; therefore, fracture risk factors besides bone mineral density are not sufficiently reflected in the results. Finally, the screening interval is 5 years, which appears to be excessively longer than the interval of cancer screening. The Fracture Risk Assessment Tool (FRAX(®)) and locomotion check are useful methods for solving these problems. The addition of these two tools to the specific health check-ups increased the participation of patients from Asahi-machi compared with that previously observed ; the use of these tools was inexpensive. Furthermore, education and enlightenment regarding osteoporosis are important to increase the osteoporosis medical treatment rate and to spread awareness regarding osteoporosis screening through osteoporosis liaison services.
日本目前较低的骨质疏松症治疗率(20%)存在问题。需要进行骨质疏松症筛查,以确保识别并治疗无症状的骨质疏松症患者。然而,日本的骨质疏松症筛查存在五个问题。首先,在1783个地区市町村中,2011年只有1062个市町村开展了骨质疏松症筛查。每年的执行率约为60%。筛查常常因经济原因而未进行。其次,筛查参与率较低,且各地区有所不同(0 - 15%)。第三,骨密度测量设备在骨质疏松症筛查方面的供应不足且不够广泛。第四,筛查结果主要由骨密度决定;因此,除骨密度外的骨折风险因素在结果中未得到充分体现。最后,筛查间隔为5年,这似乎比癌症筛查间隔长得过多。骨折风险评估工具(FRAX(®))和运动检查是解决这些问题的有效方法。将这两种工具添加到特定健康检查中,与之前相比,旭町患者的参与度有所提高;使用这些工具成本较低。此外,关于骨质疏松症的教育和宣传对于提高骨质疏松症医疗治疗率以及通过骨质疏松症联络服务普及骨质疏松症筛查意识很重要。